These findings highlight the multifaceted role of inflammasomes in hypertension pathogenesis and suggest that targeting inflammasome pathways, beyond just NLRP3, may offer novel therapeutic strategies for hypertension management. The gene discussed is NLRP3; the disease is Hypertension.